|
Bushey, Ryan T; Chen, Gang; Blevins-Primeau, Andrea S et al. (2011) Characterization of UDP-glucuronosyltransferase 2A1 (UGT2A1) variants and their potential role in tobacco carcinogenesis. Pharmacogenet Genomics 21:55-65
|
|
Strudwick, Stephen; Carastro, Louis Michael; Stagg, Tazia et al. (2003) Differential transcription-coupled translational inhibition of human p53 expression: a potentially important mechanism of regulating p53 expression in normal versus tumor tissue. Mol Cancer Res 1:463-74
|
|
Liu, S; Park, J Y; Schantz, S P et al. (2001) Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer. Oral Oncol 37:437-45
|
|
Park, L Y; Muscat, J E; Kaur, T et al. (2000) Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians. Pharmacogenetics 10:123-31
|
|
Kaur, T B; Travaline, J M; Gaughan, J P et al. (2000) Role of polymorphisms in codons 143 and 160 of the O6-alkylguanine DNA alkyltransferase gene in lung cancer risk. Cancer Epidemiol Biomarkers Prev 9:339-42
|
|
Ren, Q; Murphy, S E; Dannenberg, A J et al. (1999) Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by rat UDP-glucuronosyltransferase 2B1. Drug Metab Dispos 27:1010-6
|
|
Qin, G Z; Park, J Y; Chen, S Y et al. (1999) A high prevalence of p53 mutations in pre-malignant oral erythroplakia. Int J Cancer 80:345-8
|
|
Park, J Y; Schantz, S P; Stern, J C et al. (1999) Association between glutathione S-transferase pi genetic polymorphisms and oral cancer risk. Pharmacogenetics 9:497-504
|
|
Lazarus, P; Sheikh, S N; Ren, Q et al. (1998) p53, but not p16 mutations in oral squamous cell carcinomas are associated with specific CYP1A1 and GSTM1 polymorphic genotypes and patient tobacco use. Carcinogenesis 19:509-14
|
|
Sheikh, S N; Lazarus, P (1997) Re-usable DNA template for the polymerase chain reaction. Nucleic Acids Res 25:3537-42
|
Showing the most recent 10 out of 14 publications
